Amgen Inc. Stock
€242.25
Your prediction
Amgen Inc. Stock
Pros and Cons of Amgen Inc. in the next few years
Pros
Cons
Performance of Amgen Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Amgen Inc. | -0.100% | 3.921% | -3.213% | -19.755% | -3.213% | 4.797% | 14.711% |
Regeneron Pharmaceuticals Inc. | -3.660% | 3.739% | 0.438% | -50.756% | -25.340% | -27.806% | 3.526% |
Exact Sciences | 1.050% | -0.077% | 12.034% | -27.742% | -16.541% | 30.024% | -27.081% |
Incyte Corp. | 0.950% | 1.670% | -1.020% | 21.935% | 9.282% | 4.847% | -3.168% |

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Die Geldeinnahmen von Amgen (US-Symbol AMGN) deuten auf eine starke Leistung hin, die sich in entscheidenden Finanzmetriken wie Umsatz, Betriebskapital und Rentabilität widerspiegelt. Die Bilanzen des Unternehmens über die Jahre zeigen eine beständige Vermögensbasis und anhaltende Rentabilität. Die Analyse der Cashflow-Berichte zeigt, dass das Unternehmen robuste Betriebscashflows generiert, was auf solide betriebliche Leistung und Liquiditätsmanagement hindeutet.
Gehen wir tiefer in die einzelnen Vorteile und Nachteile der Finanzen von Amgen ein.
Die umfangreichen Vermögenswerte von Amgen, wie in den Jahresbilanzen gezeigt, beinhalten sowohl kurzfristige Vermögenswerte, die eine starke Liquidität signalisieren, als auch längerfristige Vermögenswerte, die eine solide Investition in den Forschungs- und Entwicklungsbereich verdeutlichen.
Comments
News

Here Is My Top Stock Pick Among the Weight Loss Industry Leaders
The new generation of effective weight loss drugs has generated billions of dollars for industry leaders Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), and opened the door for companies such as

2 Healthcare Dividend Stocks to Buy and Hold
Between labor-market data and potential interest-rate cuts, Wall Street has a lot on its plate right now. In an environment like this one, it can be helpful to invest in solid, dividend-paying

If You'd Invested $10,000 in Amgen Stock (AMGN) 3 Years Ago, Here's How Much You'd Have Today
Quick -- what were you doing back in September of 2022? Were you buying $10,000 of stock in Amgen (NASDAQ: AMGN)? If so, you might be wondering what that's worth today. Even if you didn't buy Amgen